TRT and HGH stacking claims: what the evidence actually supports

What did @coach.agz actually say?

The core argument here is that feeling worse on TRT is almost never the testosterone's fault. It's the clinic's fault for not tracking biomarkers. The creator lists specific systems he says testosterone disrupts: estradiol conversion, SHBG, hematocrit, prolactin, and thyroid and insulin sensitivity. His headline claim is that "95% of guys that feel worse on TRT don't need more testosterone, they need dose adjustments, injection frequency changes, estrogen management." That's a bold, specific number. It deserves scrutiny.

He's also selling something indirectly. The "comment labs" call-to-action is a lead generation tool, likely funneling viewers toward coaching services. That doesn't automatically make the content wrong, but it's worth knowing before you start typing in the comments.

Does the science back this up?

Mostly, yes, though some of it is oversimplified. The claim that testosterone "triggers multiple systems" simultaneously is accurate and well-documented. Exogenous testosterone suppresses the hypothalamic-pituitary axis, which alters endogenous hormone production across the board. Estradiol conversion via aromatase is real and clinically relevant. Hematocrit elevation is one of the most consistently documented side effects of TRT, with studies showing increases of 3-7 percentage points on average (Bachman et al., 2010, Journal of Clinical Endocrinology and Metabolism).

SHBG's role in binding testosterone and reducing free testosterone bioavailability is legitimate pharmacology. When SHBG is elevated, total testosterone numbers can look excellent on paper while the biologically active fraction remains low. This is a real clinical problem that many primary care providers miss. Prolactin's impact on libido is also supported, though it's more commonly a concern in hypogonadism caused by pituitary pathology than in standard TRT patients.

The 95% figure, however, is not from any published study. It reads like clinical intuition dressed up as a statistic.

What did they get wrong (or right)?

He got the physiology broadly right. The systems he lists, estradiol, SHBG, hematocrit, prolactin, thyroid, and glucose metabolism, are all legitimately affected by androgen therapy and are all tracked in responsible TRT protocols. The Endocrine Society's clinical practice guidelines (Bhasin et al., 2018, Journal of Clinical Endocrinology and Metabolism) explicitly recommend monitoring hematocrit, PSA, and testosterone levels at minimum during TRT, and many specialist providers go further.

What he got wrong, or at least imprecise: thyroid function is not directly altered by testosterone in most patients. The relationship is indirect and variable. Lumping it into the same list as estradiol conversion implies a more direct mechanism than evidence supports. He also doesn't distinguish between primary hypogonadism and secondary hypogonadism, or between patients on medically supervised TRT and those self-administering. That distinction matters enormously for what "blood work" even means in context.

The engine-and-dashboard metaphor is clunky but the underlying point is defensible. Ignoring labs while on exogenous testosterone is genuinely risky.

What should you actually know?

If you're on TRT and feeling worse, the creator's instinct to look at labs before changing doses is correct. But the right person to interpret those labs is a licensed clinician, not a TikTok coach, regardless of how knowledgeable they sound. Estrogen management in particular, meaning the use of aromatase inhibitors like anastrozole, carries real risks if done without proper clinical oversight. Crashing estradiol causes joint pain, mood instability, and cardiovascular strain. That's not a minor inconvenience.

The claim that most TRT failures come from poor monitoring rather than poor candidacy is plausible but unproven at scale. Some men genuinely aren't good candidates for TRT regardless of how carefully it's monitored. Baseline cardiovascular risk, sleep apnea, and fertility goals are all factors a lab panel won't fully capture.

• Hematocrit should be checked at 3-6 months after starting TRT and annually thereafter per Endocrine Society guidelines.
• Free testosterone, not just total, is the more clinically meaningful number in patients with suspected SHBG abnormalities.
• Prolactin elevation warrants pituitary imaging to rule out adenoma before attributing it to TRT.
• Thyroid panels are worth running in symptomatic patients, but testosterone does not directly suppress thyroid function in most cases.

Bottom line verdict

This video is better than most TRT content on TikTok. The physiology is largely accurate, the call for monitoring over guesswork is sound, and the skepticism toward dose escalation as a default response is clinically reasonable. The 95% statistic is made up, the thyroid claim is a stretch, and the coaching funnel at the end is a commercial pitch. Take the general message seriously. Get your labs read by someone with a medical license.